HIF-1 signaling: A key orchestrator of cancer radioresistance
Authors:
- Ruixue HuangRHRuixue Huang
- Ping-Kun ZhouPZPing-Kun Zhou
Open Access
- 1 March 2020
- journal article
- review article
- Published by KEAI Publishing in Radiation Medicine and Protection
- Vol. 1 (1) , 7-14
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (U1803124, 31870847, 31530085)
This publication has 77 references indexed in Scilit:
- Exosomes in Cancer RadioresistanceFrontiers in Oncology, 2019
- Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4British Journal of Cancer, 2018
- What is the impact of innovation on output in healthcare with a special focus on treatment innovations in radiotherapy? A literature reviewBritish Journal of Radiology, 2017
- Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?Science China Life Sciences, 2017
- Recent Developments in RadiotherapyNew England Journal of Medicine, 2017
- In Vivo Imaging Reveals Significant Tumor Vascular Dysfunction and Increased Tumor Hypoxia-Inducible Factor-1α Expression Induced by High Single-Dose Irradiation in a Pancreatic Tumor ModelInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Hypoxia-inducible factor 1–mediated characteristic features of cancer cells for tumor radioresistanceJournal of Radiation Research, 2016
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapyTrends in Pharmacological Sciences, 2012
- HIF-1–Dependent Stromal Adaptation to Ischemia Mediates In Vivo Tumor Radiation ResistanceMolecular Cancer Research, 2011
- Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factorProceedings of the National Academy of Sciences, 2002